Download PDF
Thromb Haemost 2008; 99(01): 99-240
DOI: 10.1160/TH07-08-0520
Letters to the Editor
Schattauer GmbH

β2-adrenergic receptor polymorphism and venous thromboembolism

Aaron R Folsom
1   Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, USA
,
James M Peacock
1   Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, USA
,
Eric Boerwinkle
2   University of Texas Health Science Center, Human Genetics Center and Institute of Molecular Medicine, Houston, Texas, USA
,
Mary Cushman
3   Departments of Medicine and Pathology, University of Vermont, Colchester, Vermont, USA
› Author Affiliations
Further Information

Publication History

Received: 24 August 2007

Accepted after major revision: 03 October 2007

Publication Date:
24 November 2017 (online)

   Permissions and Reprints

 

 

  • References

  • 1 Zee RYL, Cook NR, Cheng S. et al. Polymorphism in the β2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: A multilocus, population-based, prospective genetic analysis. Circulation 2006; 113: 2193-2200.
    CrossrefPubMedGoogle Scholar
  • 2 Nossent AY, Dai L, Rosendaal FR. et al. Beta 2 adrenergic receptor polymorphisms: association with factor VIII and von Willebrand factor levels and the risk of venous thrombosis. J Thromb Haemost 2005; 3: 405-407.
    CrossrefPubMedGoogle Scholar
  • 3 O’Donnell J, Manning RA, Laffan MA. Beta-adrenergic receptor polymorphisms in patients with elevated factor VIII levels with venous thrombosis. Br J Haematol 2003; 123: 139-141.
    CrossrefPubMedGoogle Scholar
  • 4 The ARIC Investigators.. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives. Am J Epidemiol 1989; 129: 687-702.
    CrossrefPubMedGoogle Scholar